Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2

Macular Telangiectasia Type 2 Clinical Trial

Official title:
Phase II, Multicenter, Open-label Safety Study of Bilateral NT-501 in Participants With Macular Telangiectasia Type 2

Status Completed

Clinical Trial Summary

This is a multi-center, open-label, 6-month study to evaluate the safety of bilateral CNTF implants in participants with Macular Telangiectasia Type 2.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04729972
Study type	Interventional
Source	Neurotech Pharmaceuticals
Contact
Status	Completed
Phase	Phase 2
Start date	August 13, 2021
Completion date	December 23, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03316300` - A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A	Phase 3
Not yet recruiting	`NCT06397131` - A Study to Determine the Safety and Efficacy of NT-501 With MHFM	Phase 3
Completed	`NCT03319849` - A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2	Phase 3
Active, not recruiting	`NCT04907084` - Serine and Fenofibrate Study in Patients With MacTel Type 2	Phase 2
Completed	`NCT01949324` - A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel	Phase 2